Filing Flows › RxSight (RXST) › Q2 2026 › vs Q1 2026
RxSight (RXST) Q2 2026 vs Q1 2026 (quarter over quarter)
RxSight's revenue rose $2.8M (+9%) from $30.9M in Q1 2026 to $33.7M in Q2 2026.
RxSight, Q2 2026: revenue $33.7M (+0.3% year over year), operating margin -40.8%, net loss $12.1M, operating cash flow −$9.5M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $33.7M | $30.9M | $2.8M | +9% |
| Other income, net | $1.8M | $2.0M | −$190K | -10% |
| Net loss | $12.1M | $15.9M | −$3.8M | -24% |
| Costs & expenses | $47.6M | $48.7M | −$1.1M | -2% |
| Operating costs | $47.5M | $48.7M | −$1.2M | -2% |
| Income tax | $88K | $6K | $82K | 15× |
| Research & development | $9.2M | $9.5M | −$235K | -2% |
| SG&A | $30.4M | $31.9M | −$1.4M | -5% |
| Operating cash sources | $18.0M | $19.7M | −$1.7M | -8% |
| Depreciation & amortization | $999K | $834K | $165K | +20% |
| Share-based compensation | $7.5M | $7.9M | −$480K | -6% |
| Cash used in operations | $9.5M | $10.9M | −$1.4M | -12% |
| Net loss absorbed | $12.1M | $15.9M | −$3.8M | -24% |
| Working capital & other | $5.9M | $3.8M | $2.1M | +56% |
Questions
How much did RxSight's revenue grow quarter over quarter in Q2 2026?
RxSight's revenue rose $2.8M (+9%) from $30.9M in Q1 2026 to $33.7M in Q2 2026.